Literature DB >> 25586087

Fecal calprotectin evaluation in patients with ulcerative colitis.

Tolga Dogan1, Mehmet Agilli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25586087     DOI： 10.1007/s10620-015-3527-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Authors:  Jost Langhorst; Sigrid Elsenbruch; Julia Koelzer; Andreas Rueffer; Andreas Michalsen; Gustav J Dobos
Journal:  Am J Gastroenterol       Date:  2007-10-04       Impact factor: 10.864

2.  Stability of the maternal gut microbiota during late pregnancy and early lactation.

Authors:  Ted Jost; Christophe Lacroix; Christian Braegger; Christophe Chassard
Journal:  Curr Microbiol       Date:  2013-11-21       Impact factor: 2.188

3.  Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals.

Authors:  Ovidiu S Cotoi; Pontus Dunér; Nayoung Ko; Bo Hedblad; Jan Nilsson; Harry Björkbacka; Alexandru Schiopu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-07       Impact factor: 8.311

4.  Probiotics on fecal calprotectin of cystic fibrosis. Reply.

Authors:  Azizollah Yousefi; Arezoo Shafieyoun; Gholamhossein Fallahi; Nima Rezaei
Journal:  Turk J Pediatr       Date:  2014 May-Jun       Impact factor: 0.552

5.  Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.

Authors:  Emanuel Burri; Christoph Beglinger; Stefanie von Felten; Frank Serge Lehmann
Journal:  Dig Dis Sci       Date:  2014-10-26       Impact factor: 3.199

6.  Fecal calprotectin levels in patients with cystic fibrosis.

Authors:  Mehmet Ağıllı; İbrahim Aydın; Fevzi Nuri Aydın
Journal:  Turk J Pediatr       Date:  2014 May-Jun       Impact factor: 0.552

7.  Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study.

Authors:  Seth D Crockett; Richard A Hansen; Til Stürmer; Robin Schectman; Jane Darter; Robert S Sandler; Michael D Kappelman
Journal:  Inflamm Bowel Dis       Date:  2011-08-08       Impact factor: 5.325

8.  The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.

Authors:  Anders Lasson; Per-Ove Stotzer; Lena Öhman; Stefan Isaksson; Maria Sapnara; Hans Strid
Journal:  J Crohns Colitis       Date:  2015-01       Impact factor: 9.071

9.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

Review 10.  Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.

Authors:  Yezaz A Ghouri; David M Richards; Erik F Rahimi; Joseph T Krill; Katherine A Jelinek; Andrew W DuPont
Journal:  Clin Exp Gastroenterol       Date:  2014-12-09
View more
  1 in total

1.  Preventive Effect of Cardiotrophin-1 Administration before DSS-Induced Ulcerative Colitis in Mice.

Authors:  Ana I Sánchez-Garrido; Vanessa Prieto-Vicente; Víctor Blanco-Gozalo; Miguel Arévalo; Yaremi Quiros; Daniel López-Montañés; Francisco J López-Hernández; Antonio Rodríguez-Pérez; José M López-Novoa
Journal:  J Clin Med       Date:  2019-12-01       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.